61 to 70 of 446 Results
R Syntax - 10.2 KB -
MD5: aaf7645ddab25a97699d98e782e29c45
|
MS Excel Spreadsheet - 89.3 KB -
MD5: 7fae40a294b6659621d85ab29b83dfd9
This Excel workbook includes all the files presented here in CSV format. |
Comma Separated Values - 3.7 KB -
MD5: 1fe55a57a64da20eb0494eafcbc98a21
|
Tabular Data - 90.3 KB - 8 Variables, 2393 Observations - UNF:6:XelH/A8OCv6tLH3kcLB80Q==
|
Comma Separated Values - 2.2 KB -
MD5: fb7855b5d1f56a6bf122891243764359
|
Adobe PDF - 91.8 KB -
MD5: e2b19efdbaf9818d7c2d0e3a557246a0
|
Plain Text - 6.1 KB -
MD5: ae95a56062f6012e562bf0cbcee0804d
|
Tabular Data - 1012 B - 5 Variables, 40 Observations - UNF:6:U1IvOYy0ZRLtODboZp/3QA==
|
Feb 6, 2025 - Harvard Dataverse
Kiyuka, Patience, 2024, "Replication Data for: Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine and its resistance in Kilifi, study protocol", https://doi.org/10.7910/DVN/JV8E9M, Harvard Dataverse, V2
We provide details of our study protocol that seeks to investigate the prevalence of Plasmodium falciparum, drug resistance and gametocyte carriage in women under intermittent preventive treatment with sulfadoxine-pyrimethamine |
MS Word - 33.1 KB -
MD5: 9f0a8915fec3565fdaffab6dbde5c31a
This study adheres to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines for cross-sectional studies. |